W. Wickemeyer

发表

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

Percutaneous cardiopulmonary bypass: application and indication for use.

W. Wickemeyer, S. Phillips, A. Grignon, 1989, The Annals of thoracic surgery.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings.

W. Tang, D. Hettrick, P. Brady, 2011, Journal of cardiac failure.

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

M. Pfeffer, J. Rouleau, F. Sacks, 1995, The American journal of cardiology.

The Role of a Third and Possible Fourth Coronary Angioplasty for Recurrent Stenosis

W. Wickemeyer, L. Iannone, T. Brown, 1990 .

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report.

K. Min, W. Wickemeyer, S. Phillips, 1987, The Journal of heart transplantation.

Left Ventricular Diastolic Performance At Rest and During Exercise in Patients With Coronary Artery Disease: Assessment with First‐pass Radionuclide Angiography

R. Miller, M. Quiñones, James B. Young, 1981, Circulation.

Comparison of effectiveness and safety of simvastatin in patients <75 versus > or =75 years of age with coronary, cerebral, or peripheral arterial disease.

Jennifer G. Robinson, J. Robinson, W. Wickemeyer, 2002, The American journal of cardiology.

The effect of digoxin on mortality and morbidity in patients with heart failure.

E. J. Brown, Hack, D. M. Barr, 1997, The New England journal of medicine.

Benefits of combined balloon pumping and percutaneous cardiopulmonary bypass.

M. Verhey, M. Tannenbaum, W. Wickemeyer, 1992, The Annals of thoracic surgery.

Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

D. M. Barr, D. F. Hughes, R. Collins, 1996, Controlled clinical trials.

Surgery for evolving myocardial infarction.

W. Wickemeyer, S. Phillips, C. Kongtahworn, 1982, JAMA.

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

D. Hettrick, P. Brady, W. Wickemeyer, 2009, Journal of cardiac failure.

A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol < or = 100 mg/dl.

W. Wickemeyer, J. G. Robinson, C. Conroy, 2000, The American journal of cardiology.

Association between Atrial and Ventricular Tachyarrhythmias, Intrathoracic Impedance and Heart Failure Decompensation in CRT-D Patients

P. Brady, W. Wickemeyer, S. Sarkar, 2007 .